Oxford’s Sarah Gilbert Outlines Coronavirus Vaccine Plans
Hopes COVID-19 Jab And Manufacturing Capacity Ready By September
Oxford University vaccines expert Sarah Gilbert says the first UK vaccine candidate to prevent the SARS-CoV-2 coronavirus will begin clinical testing in healthy volunteers next week and that “prospects are very good” an effective COVID19 jab could be available by September.
You may also be interested in...
The US behemoth and its German partner have said that if their mRNA vaccine proves to be safe and effective, it could be ready for US distribution by the end of the year.
The University of Oxford spin-out is backing its academic partners to succeed against COVID-19 – but must also look to its own commercial future using the same adenovirus platform.
Coronavirus Update: AstraZeneca To Develop Oxford’s Vaccine, Adaptive Trial Delivers Remdesivir's Good News
AstraZeneca is to develop and distribute Oxford's COVID-19 vaccine candidate in collaboration with Vaccitech. Its developers believe it could be available as early as September.